Quoin Pharma Shares Double After FDA Grants Clearance for Teens in QRX003 Trial
Quoin Pharma Shares Double After FDA Grants Clearance for Teens in QRX003 Trial
美國食品藥品管理局批准青少年參與 QRX003 試驗後,Quoin Pharma 的股價翻了一番
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊